These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 9283682

  • 1. Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries.
    Plane F, Holland M, Waldron GJ, Garland CJ, Boyle JP.
    Br J Pharmacol; 1997 Aug; 121(8):1509-11. PubMed ID: 9283682
    [Abstract] [Full Text] [Related]

  • 2. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
    White R, Hiley CR.
    Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
    [Abstract] [Full Text] [Related]

  • 3. Anandamide and endothelium-derived hyperpolarizing factor act via a common vasorelaxant mechanism in rat mesentery.
    Randall MD, Kendall DA.
    Eur J Pharmacol; 1998 Apr 03; 346(1):51-3. PubMed ID: 9617751
    [Abstract] [Full Text] [Related]

  • 4. The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide.
    O'Sullivan SE, Kendall DA, Randall MD.
    Br J Pharmacol; 2005 Jun 03; 145(4):514-26. PubMed ID: 15821751
    [Abstract] [Full Text] [Related]

  • 5. Studies on the effects of anandamide in rat hepatic artery.
    Zygmunt PM, Högestätt ED, Waldeck K, Edwards G, Kirkup AJ, Weston AH.
    Br J Pharmacol; 1997 Dec 03; 122(8):1679-86. PubMed ID: 9422814
    [Abstract] [Full Text] [Related]

  • 6. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
    Járai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, Razdan RK, Zimmer A, Kunos G.
    Proc Natl Acad Sci U S A; 1999 Nov 23; 96(24):14136-41. PubMed ID: 10570211
    [Abstract] [Full Text] [Related]

  • 7. A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation.
    Ishioka N, Bukoski RD.
    J Pharmacol Exp Ther; 1999 Apr 23; 289(1):245-50. PubMed ID: 10087011
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of the production of endothelium-derived hyperpolarizing factor by cannabinoid receptor agonists.
    Fleming I, Schermer B, Popp R, Busse R.
    Br J Pharmacol; 1999 Feb 23; 126(4):949-60. PubMed ID: 10193775
    [Abstract] [Full Text] [Related]

  • 9. Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery.
    Randall MD, McCulloch AI, Kendall DA.
    Eur J Pharmacol; 1997 Aug 27; 333(2-3):191-7. PubMed ID: 9314035
    [Abstract] [Full Text] [Related]

  • 10. Mesenteric vasodilation mediated by endothelial anandamide receptors.
    Wagner JA, Varga K, Járai Z, Kunos G.
    Hypertension; 1999 Jan 27; 33(1 Pt 2):429-34. PubMed ID: 9931142
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.
    White R, Ho WS, Bottrill FE, Ford WR, Hiley CR.
    Br J Pharmacol; 2001 Oct 27; 134(4):921-9. PubMed ID: 11606334
    [Abstract] [Full Text] [Related]

  • 12. Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries.
    Vanheel B, Van de Voorde J.
    J Pharmacol Exp Ther; 2001 Feb 27; 296(2):322-8. PubMed ID: 11160613
    [Abstract] [Full Text] [Related]

  • 13. Role of Ca2+-dependent potassium channels in in vitro anandamide-mediated mesenteric vasorelaxation in rats with biliary cirrhosis.
    Yang YY, Lin HC, Huang YT, Lee TY, Hou MC, Wang YW, Lee FY, Lee SD.
    Liver Int; 2007 Oct 27; 27(8):1045-55. PubMed ID: 17845532
    [Abstract] [Full Text] [Related]

  • 14. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
    Herradón E, Martín MI, López-Miranda V.
    Br J Pharmacol; 2007 Nov 27; 152(5):699-708. PubMed ID: 17704831
    [Abstract] [Full Text] [Related]

  • 15. An endogenous cannabinoid as an endothelium-derived vasorelaxant.
    Randall MD, Alexander SP, Bennett T, Boyd EA, Fry JR, Gardiner SM, Kemp PA, McCulloch AI, Kendall DA.
    Biochem Biophys Res Commun; 1996 Dec 04; 229(1):114-20. PubMed ID: 8954092
    [Abstract] [Full Text] [Related]

  • 16. Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation.
    Randall MD, Kendall DA.
    Eur J Pharmacol; 1997 Sep 24; 335(2-3):205-9. PubMed ID: 9369375
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries.
    O'Sullivan SE, Kendall DA, Randall MD.
    Br J Pharmacol; 2004 Jun 24; 142(3):435-42. PubMed ID: 15148250
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the pharmacological properties of EDHF-mediated vasorelaxation in guinea-pig cerebral and mesenteric resistance vessels.
    Dong H, Jiang Y, Cole WC, Triggle CR.
    Br J Pharmacol; 2000 Aug 24; 130(8):1983-91. PubMed ID: 10952691
    [Abstract] [Full Text] [Related]

  • 19. Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries.
    Chataigneau T, Félétou M, Thollon C, Villeneuve N, Vilaine JP, Duhault J, Vanhoutte PM.
    Br J Pharmacol; 1998 Mar 24; 123(5):968-74. PubMed ID: 9535027
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.